2022
DOI: 10.3390/pharmaceutics14020454
|View full text |Cite
|
Sign up to set email alerts
|

Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species

Abstract: Temporins are one of the largest families of antimicrobial peptides with both anti-inflammatory and antimicrobial activity. Herein, for a panel of cyclic temporin L isoform analogues, the antifungal and antibiofilm activities were determined against representative Candida strains, including C. albicans, C. glabrata, C. auris, C. parapsilosis and C. tropicalis. The outcomes indicated a significant anti-candida activity against planktonic and biofilm growth for four peptides (3, 7, 15 and 16). The absence of tox… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
22
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(28 citation statements)
references
References 48 publications
4
22
0
Order By: Relevance
“…In recent years, the search for new therapeutic approaches with different targets or mechanisms of action has been constantly evolving [ 64 , 67 ], and several authors have proposed AMPs, and temporins, as promising scaffolds for the development of new antifungal compounds [ 13 , 14 , 16 , 23 , 24 , 25 , 68 ]. Our group and others have described the antifungal activity of temporins L and B [ 69 , 70 ]. A series of cyclic analogs of temporin L was tested against a panel of Candida species with MIC of 50 µM.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In recent years, the search for new therapeutic approaches with different targets or mechanisms of action has been constantly evolving [ 64 , 67 ], and several authors have proposed AMPs, and temporins, as promising scaffolds for the development of new antifungal compounds [ 13 , 14 , 16 , 23 , 24 , 25 , 68 ]. Our group and others have described the antifungal activity of temporins L and B [ 69 , 70 ]. A series of cyclic analogs of temporin L was tested against a panel of Candida species with MIC of 50 µM.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, in comparison, some isoforms of temporin L were able to provoke an almost complete inhibition of biofilm formation and/or eradication at 25 µM. The same authors also hypothesized a local membrane permeabilization, with a type of carpet model, as the plausible mechanism of fungicidal activity [ 70 ]. Recently, a significant antifungal activity of temporin SHa analog was also observed, against a panel of yeasts and molds of clinical interest, with a synergistic effect when combined with amphotericin B [ 71 ].…”
Section: Discussionmentioning
confidence: 99%
“…The rigid structure of biofilms formed by extracellular polymeric substances (EPS) creates a barrier against the penetration of antimicrobial agents [121]. Most antimicrobial agents are designed to treat planktonic pathogens and result ineffective at treating biofilm infections [122,123]. The development of new therapeutic strategies against biofilms, especially for drug-resistant bacteria/fungi, is critically necessary.…”
Section: Nv Potential Against Biofilmsmentioning
confidence: 99%
“…We have particularly focused on Temporin L (TL, FVQWFSKFLGRIL), one of the most potent temporin isoforms but also the most highly hemolytic [ 35 ]. Indeed, our previous attempts were aimed at improving its biological profile through the application of several synthetic strategies, including proline decoration [ 36 ], lipidation, and side chain-to-side chain cyclizations [ 37 , 38 , 39 , 40 ]. Several TL analogues were developed and characterized through biophysical techniques to elucidate their mode of action, some of them also displayed a wide broad-spectrum antibacterial activity and no cytotoxicity on human cells.…”
Section: Introductionmentioning
confidence: 99%